Recent reports have mentioned that PTPN22 ablation accelerates arterial thrombus formation and rat tail-bleeding time, suggesting that PTPN22 is a potential therapeutic target for cardiovascular diseases, atherosclerosis, and calcific aortic valve disease [11,117,118,119]. This evidence concerns the gene PTPN22 and atherosclerosis.